| Scott E. Woodman, MD, PHD |
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Office Address
The University of Texas MD Anderson Cancer Center
7455 Fannin Street
Unit Number: 904
Houston, TX 77054
Room Number: 1SCR2.3022
Phone: 713-792-2921
Fax: 713-563-3424
7455 Fannin Street
Unit Number: 904
Houston, TX 77054
Room Number: 1SCR2.3022
Phone: 713-792-2921
Fax: 713-563-3424
Education & Training
Degree-Granting Education | |
| 2004 | Albert Einstein College of Medicine, New York, NY, MD, Medicine |
| 2004 | Albert Einstein College of Medicine, New York, NY, PHD, Molecular Pharmacology |
| 2000 | Albert Einstein College of Medicine, New York, NY, MS, Biomedical Science |
| 1996 | Michigan State University, East Lansing, MI, MA, Philosophy |
| 1993 | Hillsdale College, Hillsdale, MI, BS, Philosophy and Biology |
Postgraduate Training | |
| 2007 | Medical Oncology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2004 | Clinical Fellowship, Internal Medicine, Harvard Medical School, Boston, MA |
| 2004 | Clinical Residency, Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA |
Board Certifications
| 2007 | American Board of Internal Medicine |
Experience/Service
Academic Appointments
Instructor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 7/2010-6/2011
Honors and Awards
| 2012 | Cancer Center Support Grant Faculty Awars, National Cancer Insitute, MD Anderson Cancer Center |
| 2011 | Rising STARS Award, University of Texas Systems |
| 2010 | Lupe C. Garcia Fellowship in Cancer Research, M. D. Anderson Cancer Center |
| 2010 | Melanoma SPORE Career Development Award, National Cancer Institute, MD Anderson Cancer Center |
| 2010 | National Eye Institute Travel Grant, Association for Research in Vision and Opthamology |
| 2009 | Merit Award, American Society for Clinical Oncology |
| 2009 | Paul Calabresi Award for Clinical Oncology, MD Anderson Cancer Center, National Institutes of Health |
| 2009 | Young Investigator Award, American Society of Clinical Oncology (ASCO) |
| 2008 | Carol Cogdell Courtney Fellowship, Melanoma Oncology, MD Anderson Cancer Center |
| 2007 | Ruth L. Kirschstein National Research Service Award, MD Anderson Cancer Center, National Institute of Health |
| 2006-2007 | Resident Teaching Award, Harvard Medical School Class of 2007 |
| 2005-2006 | Outstanding Resident Teacher Award, Harvard Medical School, Shapiro Institute |
| 2004 | Alpha Omega Alpha Honor Society, Albert Einstein College of Medicine |
| 1996-2004 | Medical Scientist Training Program Grant, National Institutes Health |
Professional Memberships
| Alpha Omega Alpha, Honor Medical Society Member, 6/2004 |
| American Society of Clinical Oncology Member, 6/2009 |
| Association for Research in Vision and Ophthalmology Member, 6/2010 |
Selected Publications
Peer-Reviewed Original Research Articles | |
| 1. | Khalili JS, Yu X, Wang J, Hayes BC, Davies MA, Lizee G, Esmaeli B, Woodman SE. Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11-Dependent Manner. Clin Cancer Res. e-Pub 7/19/2012. PMID: 22733540. |
| 2. | Griewank KG, Yu X, Khalili J, Sozen MM, Stempke-Hale K, Bernatchez C, Wardell S, Bastian BC, Woodman SE. Genetic and Molecular Characterization of Uveal Melanoma Cell Lines. PIGM CELL MELANOMA R 25(2):182-7, 3/2012. e-Pub 2/2012. PMCID: PMC3288394. |
| 3. | Woodman SE. Metastatic uveal melanoma: biology and emerging treatments. Cancer J 18(2):148-52, Mar-Apr, 3/2012. PMID: 22453016. |
| 4. | Woodman SE. BAP1tism of a Tumor Suppressor. Clin Cancer Res 18(2):323-5, 1/15/2012. e-Pub 12/2/2011. PMID: 22140212. |
| 5. | Woodman SE, Mills GB. Are oncogenes sufficient to cause human cancer? P NATL ACAD SCI USA 107(48):20599-600, 11/2010. e-Pub 11/2010. PMCID: PMC2996413. |
| 6. | Woodman SE, Trent JC, Stemke-Hale K, Lazar AJ, Pricl S, Pavan GM, Fermeglia M, Gopal YN, Yang D, Podoloff DA, Ivan D, Kim KB, Papadopoulos N, Hwu P, Mills GB, Davies MA. Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates. Mol Cancer Ther 8(8):2079-85, 8/2009. e-Pub 8/2009. PMID: 19671763. |
Last updated: 11/29/2012
- Global Navigation
- About Us
- Locations
- Calendar
- Careers
- Publications
- How You Can Help
- Contact Us
- Newsroom
- Site Index
- Patient and Cancer Information
- myMDAnderson
- Cancer Information
- Patient Information
- Care Centers & Clinics
- Children's Cancer Hospital
- Services & Amenities
- Education and Research
- Departments, Programs and Labs
- PeopleFinder
- Research at MD Anderson
- Education & Training
- Resources for Professionals
- For Employees
- Employee Alert Information
- Employee Resources
- Doing Business
- Vendors & Suppliers
- Partners & Affiliates
- Legal and Policy
- Legal Statements
- Site Policies
- Reporting Fraud, Waste & Abuse
© 2010 The University of Texas M. D. Anderson Cancer Center

